Downregulation of interleukin-7 and hepatocyte growth factor in the thymic microenvironment is associated with thymus involution in tumor-bearing mice

Cancer Immunology, Immunotherapy

Volumn 58, Issue 12, 2009, Pages 2059-2072

  Carrio, Roberto ^a   Altman, Norman H ^a   Lopez, Diana M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatocyte growth factor; IL 7; Thymus; Tumor bearing mice; Vascular endothelial growth factor

Indexed keywords

INTERLEUKIN 7; MESSENGER RNA; SCATTER FACTOR; VASCULOTROPIN A;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL DEDIFFERENTIATION; DOWN REGULATION; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETICS; HUMAN; IMMUNOLOGY; MOUSE; NEOPLASM; PATHOLOGY; THYMUS;

ANIMALS; CELL DEDIFFERENTIATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-7; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASMS; RNA, MESSENGER; THYMUS GLAND; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79958107572     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-009-0714-7     Document Type: Article

References (45)

1. Gill J, Malin M, Sutherland J, Gray D, Hollander G, Boyd R (2003) Thymic generation and regeneration. Immunol Rev 195:28-50 (Pubitemid 37153451)
2. Anderson G, Harman BC, Hare KJ, Jenkinson EJ (2000) Microenvironmental regulation of T cell development in the thymus. Semin Immunol 12:457-464
3. Ladi E, Yin X, Chtanova T, Robey EA (2006) Thymic microenvironments for T cell differentiation and selection. Nat Immunol 7:338-343
4. Takahama Y (2006) Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol 6:127-135
5. Boyd E (1932) The weight of the thymus gland in health and disease. Am J Dis Child 43:1162-1214
6. Metcalf D, Moulds R, Pike B (1967) Influence of the spleen and thymus on immune responses in ageing mice. Clin Exp Immunol 2:109-120
7. Aspinall R, Andrew D (2000) Thymic involution in aging. J Clin Immunol 20:250-256 (Pubitemid 30619396)
8. Linton PJ, Dorshkind K (2004) Age-related changes in lymphocyte development and function. Nat Immunol 5:133-139 (Pubitemid 38208354)
9. Lapp WS, Ghayur T, Mendes M, Seddik M, Seemayer TA (1985) The functional and histological basis for graft-versus-host-induced immunosuppression. Immunol Rev 88:107-133 (Pubitemid 16172493)
10. Haynes BF, Markert ML, Sempowski GD, Patel DD, Hale LP (2000) The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol 18:529-560 (Pubitemid 30365390)
11. Montecino-Rodriquez E, Min H, Dorshkind K (2005) Reevaluating current models of thymic involution. Semin Immunol 17:356-361 (Pubitemid 41058766)
12. Medina D, DeOme KB (1969) Response of hyperplastic alveolar nodule outgrowth-line D1 to mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation acting singly and in combination. J Natl Cancer Inst 42:303-310
13. Fu YX, Altman N, Lopez DM (1989) Thymic atrophy induced by murine mammary adenocarcinoma in vivo. In Vivo 3:1-5
14. Fu Y, Paul RD, Wang Y, Lopez DM (1989) Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas. J Immunol 143:4300-4307 (Pubitemid 20012631)
15. Adkins B, Charyulu V, Sun QL, Lobo D, Lopez DM (2000) Early block in maturation is associated with thymic involution in mammary tumor-bearing mice. J Immunol 164:5635-5640 (Pubitemid 30389803)
16. L and A1. Int J Mol Med 23:89-98
17. Ohm JE, Gabrilovich DI, Sempowski GD, Kisseleva E, Parman KS, Nadaf S, Carbone DP (2003) VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. Blood 101:4878-4886
18. Imado T, Iwasaki T, Kataoka Y, Kuroiwa T, Hara H, Fujimoto J, Sano H (2004) Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation. Blood 104:1542-1549 (Pubitemid 39166536)
19. Miyazawa K, Tsubouchi H, Naka D, Takahashi K, Okigaki M, Arakaki N, Nakayama H, Hirono S, Sakiyama O, Takahashi K et al (1989) Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 163:967-973 (Pubitemid 19236944)
20. Zarnegar R, Michalopoulos GK (1995) The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 129:1177-1180
21. + T cells competent to develop into memory cells that are activated in an antigen-free, IL-7- and IL-15-rich environment. J Immunol 172:7315-7323
22. Carrio R, Lopez-Hoyos M, Jimeno J, Benedict MA, Merino R, Benito A, Fernandez-Luna JL, Nunez G, Garcia-Porrero JA, Merino J (1996) A1 demonstrates restricted tissue distribution during embryonic development and functions to protect against cell death. Am J Pathol 149:2133-2142 (Pubitemid 26415229)
23. Jin H, Carrio R, Yu A, Malek TR (2004) Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J Immunol 173:657-665 (Pubitemid 38797396)
24. Yang J, Dai C, Liu Y (2001) Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice. Gene Ther 8:1470-1479 (Pubitemid 32994658)
25. 33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach. J Pharm Sci 85:612-618
26. Owen JL, Iragavarapu-Charyulu V, Gunja-Smith Z, Herbert LM, Grosso JF, Lopez DM (2003) Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor. J Immunol 171:4340-4351 (Pubitemid 37238712)
27. Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, Isner JM (1998) Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 97:381-390 (Pubitemid 28074339)
28. Gille J, Khalik M, Konig V, Kaufmann R (1998) Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes. J Invest Dermatol 111:1160-1165 (Pubitemid 29115191)
29. Wojta J, Kaun C, Breuss JM, Koshelnick Y, Beckmann R, Hattey E, Mildner M, Weninger W, Nakamura T, Tschachler E, Binder BR (1999) Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor Xk-1 in human endothelial cells. Lab Invest 79:427-438 (Pubitemid 29190432)
30. Sun QL, Charyulu V, Lobo D, Lopez DM (2002) Role of thymic stromal cell dysfunction in the thymic involution of mammary tumor-bearing mice. Anticancer Res 22:91-96 (Pubitemid 34475280)
31. Watson GA, Fu YX, Lopez DM (1991) Splenic macrophages from tumor-bearing mice co-expressing MAC-1 and MAC-2 antigens exert immunoregulatory functions via two distinct mechanisms. J Leukoc Biol 49:126-138
32. Fu YX, Watson G, Jimenez JJ, Wang Y, Lopez DM (1990) Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. Cancer Res 50:227-234 (Pubitemid 20041218)
33. Lopez DM, Lopez-Cepero M, Watson GA, Ganju A, Sotomayor E, Fu YX (1991) Modulation of the immune system by mammary tumor-derived factors. Cancer Invest 9:643-653
34. Calderon C, Huang ZH, Gage DA, Sotomayor EM, Lopez DM (1994) Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidyl serine. J Exp Med 180:945-958 (Pubitemid 24256607)
35. Aherne WA, Zaitoun AM, Lauder I, Hull DL (1980) Cytokinetic changes in the thymus of tumour-bearing and of dexamethasone-treated mice. Cell Tissue Kinet 13:485-495 (Pubitemid 10039535)
36. Taub DD, Longo DL (2005) Insights into thymic aging and regeneration. Immunol Rev 205:72-93 (Pubitemid 40780178)
37. Min H, Montecino-Rodriguez E, Dorshkind K (2006) Reassessing the role of growth hormone and sex steroids in thymic involution. Clin Immunol 118:117-123 (Pubitemid 43012054)
38. Hadden JW (1998) Thymic endocrinology. Ann N Y Acad Sci 840:352-358
39. Huang Y, Chen X, Dikov MM, Novitskiy SV, Mosse CA, Yang L, Carbone DP (2007) Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF. Blood 110:624-631 (Pubitemid 47105401)
40. Porter BO, Malek TR (2000) Thymic and intestinal intraepithelial T lymphocyte development are each regulated by the gammac-dependent cytokines IL-2, IL-7, and IL-15. Semin Immunol 12:465-474
41. Ma A, Koka R, Burkett P (2006) Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol 24:657-679
42. Zamisch M, Moore-Scott B, Su DM, Lucas PJ, Manley N, Richie ER (2005) Ontogeny and regulation of IL-7-expressing thymic epithelial cells. J Immunol 174:60-67 (Pubitemid 40007392)
43. Carrio R, Rolle CE, Malek TR (2007) Non-redundant role for IL-7R signaling for the survival of CD8+ memory T cells. Eur J Immunol 37:3078-3088 (Pubitemid 350131287)
44. Lai L, Goldschneider I (2001) Cutting edge: identification of a hybrid cytokine consisting of IL-7 and the beta-chain of the hepatocyte growth factor/scatter factor. J Immunol 167:3550-3554 (Pubitemid 32910794)
45. Lai L, Zeff RA, Goldschneider I (2006) A recombinant single-chain IL-7/HGFbeta hybrid cytokine induces juxtacrine interactions of the IL-7 and HGF (c-Met) receptors and stimulates the proliferation of CFU-S12, CLPs, and pre-pro-B cells. Blood 107:1776-1784 (Pubitemid 43289353)